Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
27.91
-0.26 (-0.92%)
At close: Mar 5, 2026, 4:00 PM EST
27.91
0.00 (0.00%)
After-hours: Mar 5, 2026, 4:10 PM EST
Castle Biosciences Market Cap
Castle Biosciences has a market cap or net worth of $829.8 million as of March 5, 2026. Its market cap has increased by 8.97% in one year.
Market Cap
829.80M
Enterprise Value
567.31M
1-Year Change
8.97%
Ranking
Category
Stock Price
$27.91
Market Cap Chart
Since July 25, 2019, Castle Biosciences's market cap has increased from $123.05M to $829.80M, an increase of 574.35%. That is a compound annual growth rate of 33.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 829.80M | -26.92% |
| Dec 31, 2025 | 1.14B | 52.12% |
| Dec 31, 2024 | 746.39M | 28.53% |
| Dec 29, 2023 | 580.73M | -6.38% |
| Dec 30, 2022 | 620.32M | -43.76% |
| Dec 31, 2021 | 1.10B | -32.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veracyte | 2.88B |
| Neogen | 2.35B |
| GeneDx Holdings | 2.33B |
| GRAIL | 2.18B |
| NeoGenomics | 1.18B |
| CareDx | 976.18M |
| Personalis | 934.36M |
| OPKO Health | 910.88M |